Skip to main content
Clinical Trials/ISRCTN58235785
ISRCTN58235785
Completed
Not Applicable

Barrett’s oesophagus surveillance with optical biopsy using spectroscopy and enhanced endoscopic imaging to target high-risk lesions: a prospective cohort study

CL Biomedical Research Unit0 sites2,000 target enrollmentSeptember 30, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
CL Biomedical Research Unit
Enrollment
2000
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 30, 2016
End Date
TBD
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
CL Biomedical Research Unit

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients will be recruited from those with Barrett’s oesophagus with or without other alterations (low\-grade dysplasia \[LGD] or high\-grade dysplasia \[HGD], any oesophageal or gastric cancer) undergoing endoscopy
  • 2\. Patients without Barrett’s oesophagus attending for a clinically indicated endoscopy may be recruited as controls
  • 3\. Patients must sign an informed consent form

Exclusion Criteria

  • 1\. Patients in whom endoscopy and biopsy is contraindicated
  • 2\. Patients who are unable to give informed consent
  • 3\. Pregnant women
  • 4\. People under the age of 21 years
  • 5\. People who are non\-English speakers

Outcomes

Primary Outcomes

Not specified

Similar Trials